Charles Triano | Senior Vice President, Investor Relations |
Albert Bourla | Chief Executive Officer |
Frank D'Amelio | Chief Financial Officer |
John Young | Chief Business Officer |
Angela Hwang | Group President, Pfizer Biopharmaceuticals Group |
Mikael Dolsten | Global President, WRD & Medical |
Steve Scala | Cowen & Co. LLC |
Umer Raffat | Evercore Group LLC |
Chris Schott | J.P. Morgan Chase & Co. |
Alex Arfaei | BMO Capital Markets |
Vamil Divan | Credit Suisse Securities LLC |
Timothy Anderson | Wolfe Research, LLC |
Louise Chen | Cantor Fitzgerald |
David Risinger | Morgan Stanley |
Jason Gerberry | Bank of America Merrill Lynch |
Geoff Meacham | Barclays Capital, Inc. |
Seamus Fernandez | Guggenheim Partners |
Good day, everyone, and welcome to Pfizer's Fourth Quarter 2018 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chuck Triano, Senior Vice President of Investor Relations. Please go ahead, sir.